GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MET, PPARA, PTGES, TRPV1 |
10.472 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, GLO1, HSD17B3, PIM1, PPARA, PTGES, TYR, XDH |
8.71215 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APEX1, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, CYP3A4, F10, F3, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSD17B3, KDR, MAOA, MET, PPARA, SRC, TRPV1, XDH |
8.22434 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TOP1, TOP2A, TRPV1, TYR, XDH |
8.06012 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
7.77248 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GLO1, IGF1R, KDR, MAP2K1, MET, PIM1, PPARA, PTPN1, RELA, SRC, TOP2A, TRPV1, XDH |
7.58705 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GLO1, IGF1R, KDR, MAP2K1, MET, PIM1, PTPN1, RELA, SRC, TOP2A, TRPV1, XDH |
7.40667 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
7.05016 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, PTGES, RELA, SRC |
7.03744 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
7.03744 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GLO1, IGF1R, KDR, MAP2K1, PIM1, PTPN1, RELA, SRC, TOP2A, TRPV1, XDH |
6.75806 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
6.66615 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CYP1B1, F10, F3, FLT3, KDR, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC, XDH |
6.5244 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TOP1, TOP2A, TYR, XDH |
6.5085 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
6.23941 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, KDR, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC, XDH |
6.15988 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, APEX1, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, NR3C1, PPARA, PTGES, RELA, SRC, TRPV1, TYR |
6.15988 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, KDR, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC, XDH |
6.15988 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, PPARA, RELA, SRC, TYR |
6.15988 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7 |
6.08461 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
6.07665 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, APP, AR, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FLT3, NR3C1, PTGES, RELA, SRC, TRPV1, TYR |
5.74803 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AR, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, HSD17B2, IGF1R, NR3C1, PPARA, PTGES, RELA, SRC, TRPV1, TYR |
5.69945 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B3, MAOA, TYR |
5.69945 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, HSD17B3, PTGES |
5.34178 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.25865 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, APEX1, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, NR3C1, PPARA, PTGES, RELA, SRC, TOP1, TRPV1, TYR |
5.18314 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RELA, SRC |
5.16156 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, PTGES |
5.16156 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, MET, PPARA, PTGES |
5.10551 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES |
5.09763 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, NR3C1, PTGES, RELA, SRC, TYR |
4.9996 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES |
4.90596 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, ALOX12, APP, AR, CDC25B, CSNK2A1, CYP1B1, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, PIM1, PTGES, RELA, SRC, XDH |
4.90574 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MET, PIM1, PTPN1, RELA, SRC |
4.89208 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, F10, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC, XDH |
4.89208 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.88699 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, F10, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTPN1, RELA, SRC, TOP2A, TRPV1, XDH |
4.88075 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, APEX1, APP, AR, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MAP2K1, MET, PPARA, PTPN1, SRC, TRPV1 |
4.78808 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, F10, F3, FLT3, KDR, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC, XDH |
4.73747 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, APP, AR, AURKB, AXL, CA2, CA6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, F10, F3, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MAP2K1, MAP3K7, NR3C1, PPARA, PTGES, PTPN1, RELA, SRC, TOP1, TOP2A, TRPV1, TYR |
4.67375 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, APEX1, AR, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, NR3C1, PPARA, RELA, SRC, TRPV1 |
4.63226 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APEX1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TOP1, TOP2A, TRPV1, TYR, XDH |
4.52903 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APEX1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TOP1, TOP2A, TRPV1, TYR, XDH |
4.5102 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.45375 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, APP, AR, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, IGF1R, NR3C1, PPARA, RELA, SRC, TRPV1 |
4.30473 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, NR3C1, RELA, SRC, TRPV1 |
4.28226 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, PIM1, PTPN1, RELA, SRC |
4.24676 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGES |
4.13644 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, F10, F3, FABP3, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTPN1, RELA, SRC, TOP2A, TRPV1, XDH |
4.11036 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, APEX1, APP, AR, AURKB, AXL, CA2, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, MET, PIM1, PPARA, RELA, SRC, TOP2A, TYR |
4.10999 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ALOX12, APEX1, APP, CACNA1C, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, SRC |
4.04977 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, AR, FLT3, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
4.04927 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ALOX12, APEX1, APP, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, SRC |
3.96666 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, APEX1, APP, AR, AXL, CYP1A1, CYP1B1, FABP4, FLT3, IGF1R, KDR, NR3C1, RELA, SRC, TRPV1 |
3.96666 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES |
3.94755 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, FABP3, PPARA, TRPV1 |
3.93336 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
3.86112 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
3.86112 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, HSD17B3, TYR |
3.84979 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, PTGES |
3.84979 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.71507 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ALOX12, APEX1, APP, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, SRC |
3.71054 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, APEX1, APP, AR, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, NR3C1, PTPN1, RELA, SRC, TOP2A, TRPV1 |
3.68631 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA, SRC |
3.67767 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, RELA, SRC |
3.67767 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, IGF1R, PPARA, RELA, SRC, TRPV1 |
3.65957 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, MAP3K7, NR3C1, PIM1, PPARA, RELA, SRC |
3.65957 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, APP, AR, CYP1A1, CYP1B1, FLT3, NR3C1, SRC, TRPV1 |
3.64434 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, APEX1, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, NR3C1, RELA, SRC, TRPV1 |
3.61351 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA |
3.60084 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, AR, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
3.56722 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC, XDH |
3.5543 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.52355 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.52351 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PPARA, PTGES |
3.51289 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.49853 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, FABP3, KDR, NR3C1, RELA, SRC, TOP1, TRPV1 |
3.49392 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, F10, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, SRC, TOP1, TOP2A |
3.49383 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, RELA |
3.49383 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC, XDH |
3.49373 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, ALOX12, APEX1, APP, AXL, CA12, CA2, CA7, CACNA1C, FABP3, FABP4, FLT3, MET, SRC, TRPV1 |
3.48773 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ALOX12, APEX1, APP, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, SRC |
3.44209 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, PIM1, PPARA, RELA, SRC, TYR |
3.4293 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.4293 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AR, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, F10, F3, FABP4, HSD17B2, IGF1R, MET, PIM1, PPARA, RELA, SRC, TOP1, TRPV1, TYR |
3.42474 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HSD17B3 |
3.42474 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, APEX1, APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PTPN1, SRC, TOP1, XDH |
3.35053 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, F10, F3, FABP4, FLT3, KDR, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC, XDH |
3.30807 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, KDR, SRC, TRPV1 |
3.28408 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.26591 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, APEX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, FABP3, FABP4, GLO1, IGF1R, KDR, MAP2K1, MET, NR3C1, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TOP2A, TRPV1, XDH |
3.20318 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX12, ALOX15, ALOX5, PTGES |
3.11032 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, FABP3, PPARA, TRPV1 |
3.10821 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, APEX1, APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PTPN1, SRC, TOP1, XDH |
3.09036 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, HSD17B3, PTGES |
3.00658 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
3.00658 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.929 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, PTGES, TYR |
2.90871 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
2.86068 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
2.86068 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
2.86068 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AR, AXL, CYP1B1, IGF1R, NR3C1, RELA, SRC, TRPV1 |
2.70846 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, RELA, SRC |
2.69147 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APEX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, FABP3, FABP4, GLO1, IGF1R, KDR, MAP2K1, MET, NR3C1, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TOP2A, TRPV1, XDH |
2.68301 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5 |
2.68301 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, FABP3, FLT3, IGF1R, PPARA, RELA, SRC, TRPV1, TYR |
2.68301 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CSNK2A1, NR3C1, RELA, SRC |
2.64729 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, HSD17B2, HSD17B3, MAP2K1, SRC |
2.63712 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.60199 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, AR, CDC25B, FABP3, FLT3, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
2.57527 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, AR, CDC25B, FABP3, FLT3, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
2.57527 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ALOX12, APP, CYP19A1, F3, FABP4, IGF1R, MAP2K1, MAP3K7, MET, PPARA, PTPN1, RELA, SRC, XDH |
2.55517 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, NR3C1, PPARA, PTPN1, RELA, SRC, TOP2A, TRPV1, XDH |
2.55269 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, AR, CDC25B, FLT3, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
2.5451 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, PTGES, TYR |
2.53883 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, FLT3, MAP2K1, MET, PIM1, SRC, TYR |
2.50555 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, F10, F3, FLT3, FUT7, GLO1, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, PIM1, PPARA, PTPN1, RELA, SRC, TOP1, TOP2A, TYR, XDH |
2.49666 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, PTGES, TYR |
2.471 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, RELA, SRC |
2.46982 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, KDR, RELA, SRC |
2.46519 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.45838 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, AR, CDC25B, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, PPARA, PTPN1, SRC, XDH |
2.44872 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, ALOX12, MET, TRPV1 |
2.44574 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, FABP3, FLT3, IGF1R, PPARA, RELA, SRC, TRPV1, TYR |
2.43648 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4 |
2.426 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, AR, CDC25B, FLT3, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
2.40298 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, AR, FLT3, IGF1R, NR3C1, RELA, SRC, TRPV1 |
2.38976 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.38812 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ALOX12, APP, AR, AXL, CA2, CYP1B1, F3, KDR, MAP2K1, MAP3K7, MET, PIM1, RELA, SRC, TRPV1 |
2.3715 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, CDC25B, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, NR3C1, PPARA, PTPN1, RELA, SRC, TOP2A, TRPV1, XDH |
2.35434 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, AR, CDC25B, FABP3, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, PPARA, PTPN1, SRC, XDH |
2.35298 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.35298 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, IGF1R, RELA, SRC |
2.35114 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, F10, F3, MET, SRC, XDH |
2.32117 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, AR, CDC25B, FABP3, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, PPARA, PTPN1, SRC, XDH |
2.32031 |
[BP] GO:0006081 |
None
|
AKR1B10, CYP1B1, GLO1, RELA |
2.29116 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.28974 |
[BP] GO:0046683 |
response to organophosphorus
|
APEX1, APP, RELA, TRPV1, TYR |
2.28806 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.28781 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, AR, CDC25B, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
2.28781 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.28082 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, CA2, CYP1A1, CYP1A2, FABP4, PTGES |
2.27976 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, PTGES, RELA, SRC |
2.25634 |
[BP] GO:0048545 |
response to steroid hormone
|
AR, CA2, FLT3, NR3C1, RELA, SRC |
2.25431 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, APP, F10, F3, IGF1R, KDR, MET, SRC |
2.25331 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.25331 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.23693 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.23693 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, NR3C1, PPARA, PTPN1, RELA, SRC, TOP2A, TRPV1, XDH |
2.21517 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, AR, CDC25B, CSNK2A1, F3, FLT3, IGF1R, KDR, PIM1, RELA |
2.21517 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.17202 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, APP, F10, F3, IGF1R, KDR, MET, SRC |
2.17202 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, AR, CDC25B, CSNK2A1, F3, FLT3, KDR, MAP2K1, MAP3K7, PTPN1, RELA, SRC, XDH |
2.17202 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, IGF1R, MAP2K1, MAP3K7, PTPN1, SRC |
2.14461 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, MAOA, SRC, XDH |
2.13787 |
[BP] GO:0071383 |
None
|
AR, FLT3, NR3C1, SRC |
2.12903 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, CYP1B1, RELA, SRC |
2.12896 |
[BP] GO:0014074 |
response to purine-containing compound
|
APEX1, APP, RELA, TRPV1, TYR |
2.107 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, MAP2K1, MAP3K7, PPARA, PTGES, PTPN1, RELA, SRC, TOP2A, TRPV1 |
2.10545 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, APP, F10, F3, IGF1R, KDR, MET, SRC |
2.10545 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, HSD17B3 |
2.09453 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CACNA1C, KDR, SRC, TRPV1 |
2.0839 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, MAP2K1, RELA, TYR |
2.06941 |
[BP] GO:0034097 |
response to cytokine
|
ALOX15, AXL, FABP4, FLT3, PTGES, RELA, SRC, TRPV1 |
2.06925 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.06925 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.06925 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.06925 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.06925 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.06925 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX12, ALOX15, PTGES |
2.06769 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, KDR, NR3C1, RELA, SRC, TRPV1 |
2.06136 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F10, F3, MET, SRC |
2.05764 |
[BP] GO:1901570 |
None
|
ALOX12, ALOX15, ALOX5, PTGES |
2.03789 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, APP, F10, F3, IGF1R, KDR, MET, SRC |
2.03525 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, APP, CA12, CA2, CA7, CACNA1C, FABP3, FABP4, MET, TRPV1 |
2.02626 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, NR3C1, SRC |
2.02429 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ALOX12, CYP19A1, F3, FABP4, KDR, MAP2K1, MET, PPARA, RELA |
2.02371 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, F3, FABP3, FABP4, FLT3, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TOP1, TOP2A, TRPV1, XDH |
2.02371 |
[BP] GO:0006691 |
None
|
ALOX12, ALOX15, ALOX5 |
2.00568 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, FABP4, FLT3, IGF1R, MAP2K1, MAP3K7, PTPN1, SRC |
2.00325 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APEX1, APP, AR, AURKB, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, KDR, MAOA, MAP2K1, MAP3K7, NR3C1, PIM1, PTGES, PTPN1, RELA, SRC, TOP1, TOP2A, TRPV1, TYR, XDH |
4.4265 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.51301 |
[CC] GO:0009330 |
None
|
TOP1, TOP2A |
2.86068 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALOX5, APP, AR, AXL, CA12, CA14, CA2, CA4, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, F3, FLT3, FUT7, GLO1, HSD11B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, PIM1, PTGES, PTPN1, SRC, TRPV1, TYR |
2.75388 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.43899 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, APP, AR, AXL, CA12, CA14, CA2, CA4, CACNA1C, CSNK2A1, F10, F3, FLT3, GLO1, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PTPN1, SRC, TRPV1 |
2.17964 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, FLT3, HSD11B1, HSD17B2, HSD17B3, PTGES, PTPN1 |
2.04654 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, APP, CA4, CYP19A1, FLT3, HSD17B3, KDR, MAP2K1, PTPN1, XDH |
2.03525 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, F3, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, PIM1, PTGES, PTPN1, SRC, TOP1, TOP2A, TYR, XDH |
10.4637 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
10.217 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, IGF1R, KDR, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TOP1, TOP2A, TRPV1, TYR, XDH |
10.217 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, APP, AR, CA1, CA12, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, GLO1, NR3C1, PIM1, PPARA, PTPN1, TYR, XDH |
10.217 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
8.22434 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
7.04673 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
6.5244 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
6.07665 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, GLO1 |
5.6028 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.37356 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PPARA, SRC, TOP1, TOP2A, TRPV1 |
5.18314 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.16156 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, GLO1, MAP3K7, NR3C1, PIM1, PPARA, PTPN1, TOP2A, TRPV1, TYR, XDH |
4.88075 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, GLO1, MAP3K7, NR3C1, PIM1, PPARA, PTPN1, TOP2A, TRPV1, TYR, XDH |
4.52682 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, CYP3A4, F10, F3, FABP3, FABP4, HSD17B1, NR3C1, PPARA, SHBG, TRPV1 |
4.52682 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2, HSD17B3, XDH |
4.25415 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, NR3C1, SHBG |
4.17067 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.13644 |
[MF] GO:0043168 |
anion binding
|
ALOX15, APP, AURKB, AXL, CSNK2A1, F10, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PTGES, RELA, SRC, TOP1, TOP2A, TRPV1, XDH |
3.98469 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.94755 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
3.91681 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.58024 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.57456 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.56257 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.49856 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.48773 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.39798 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.36899 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
3.26591 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.20318 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.16869 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, HSD17B1, NR3C1, SHBG |
3.00658 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
2.94062 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
2.91571 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
2.86068 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, PTGES, SRC, XDH |
2.70974 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA6, CA7, GLO1, NR3C1, PPARA, PTPN1 |
2.46437 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.45838 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.45838 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.45838 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, FLT3, IGF1R, KDR, PIM1, PPARA, PTPN1, RELA, SRC |
2.40907 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
2.3294 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.23693 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.23693 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.23693 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1, TOP2A, TRPV1, XDH |
2.22954 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5 |
2.17202 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5 |
2.13059 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.06925 |
[MF] GO:0016853 |
None
|
ALOX12, ALOX15, PTGES, TOP1, TOP2A |
2.06547 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1, TOP2A, TRPV1 |
2.06159 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.00568 |